DLGAP5 was associated with an increase in immune‐related pathways, such as T cell receptor pathway and B cell receptor pathway (Figure 9D), This confirms the importance of these genes for hepatocellular cancer. The gene discussed is DLGAP5; the disease is hepatocellular carcinoma.